Clinical Trial Update: Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating a four-drug regimen of carfilzomib, clarithromycin, lenalidomide, and dexamethasone for multiple myeloma has results posted (March 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Biaxin (clarithromycin)
• Decadron (Dexamethasone)
• Kyprolis (carfilzomib)
• Revlimid (lenalidomide)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2017-03-22